Skip to search.
 TSX Up 0.24% TSX Ventures Up 0.49%

aTyr Pharma Inc. (LIFE)

-NasdaqGS
2.90 Down 0.06(2.03%) Jul 22, 4:00PM EDT
Prev Close:2.96
Open:2.96
Bid:2.50 x 200
Ask:2.99 x 1000
1y Target Est:8.50
Beta:1.41
Earnings Date:Aug 10 - Aug 15 (Est.)
Day's Range:2.86 - 2.96
52wk Range:2.48 - 21.00
Volume:216,137
Avg Vol (3m):215,654
Market Cap:68.78M
P/E (ttm):N/A
EPS (ttm):-2.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-2.79
Quarterly EPS Est (Jun-16) :-0.71
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback